Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $43

Benzinga · 4d ago
Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $39 to $43.